LARGO, Fla., Jan. 23 /PRNewswire-FirstCall/ -- GeoPharma, Inc. today announced that it has been invited to present at the Roth Capital Partners 18th Annual Growth Stock Conference, February 20-22, 2006 in Dana Point, CA. The conference will feature presentations from over 250 small-cap companies across a broad spectrum of sectors.
Mihir Taneja, Chief Executive Officer and Carol Dore-Falcone, Vice President and Chief Financial Officer of GeoPharma will give a presentation on the Company on Wednesday, February 22, 2006, at 3:30 p.m PST. The presentation will be webcast on the Roth Capital Partners website at www.rothcp.com through a link from the Growth Stock Conference presenters page, as well as on the GeoPharma corporate website at www.onlineihp.com.
“We look forward to sharing our story with investors at Roth,” stated Mr. Taneja. Our business continues to grow. We are executing on our strategy of developing multiple revenue streams and we are benefiting from significant investments in research and development and sales and marketing.”
GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company’s growth strategy is to capitalize on its manufacturing expertise to develop high margin generic or novel drugs for niche markets with high barriers to entry. GeoPharma’s competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at www.onlineihp.com and www.carbslim.com.
This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries’ expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company’s management as of the date hereof, and actual results may vary based upon future events, both within and without management’s control. Important factors that could cause such differences are described in the company’s periodic filings with the Securities and Exchange Commission.
GeoPharma, Inc.
CONTACT: Carol Dore-Falcone, VP/CFO of GeoPharma, +1-727-544-8866 x244E,cdf@onlineihp.com; or Investor and Media Relations: Rachel Levine of TheGlobal Consulting Group, +1-646-284-9439, rlevine@hfgcg.com
Web site: http://www.onlineihp.com/
